|
ZNF530 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.40700000000627E-05 |
| Normal-vs-Stage3 |
3.398200E-04 |
| Normal-vs-Stage4 |
1.140330E-03 |
| Stage1-vs-Stage2 |
3.382600E-01 |
| Stage1-vs-Stage3 |
1.454600E-01 |
| Stage1-vs-Stage4 |
1.422350E-01 |
| Stage2-vs-Stage3 |
6.624400E-01 |
| Stage2-vs-Stage4 |
6.167600E-01 |
| Stage3-vs-Stage4 |
9.383200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88737914186277E-15 |
| Normal-vs-AfricanAmerican |
9.58239999999666E-05 |
| Normal-vs-Asian |
3.988200E-02 |
| Caucasian-vs-AfricanAmerican |
5.150600E-01 |
| Caucasian-vs-Asian |
4.784800E-01 |
| AfricanAmerican-vs-Asian |
2.788200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.46407363799517E-12 |
| Normal-vs-Female |
1.63569158218024E-12 |
| Male-vs-Female |
5.345600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.204910E-04 |
| Normal-vs-Age(41-60Yrs) |
2.08066897045001E-12 |
| Normal-vs-Age(61-80Yrs) |
4.33679758771177E-11 |
| Normal-vs-Age(81-100Yrs) |
4.722100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.929600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.802000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.360000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.993500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.454230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.443400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.58739737705127E-11 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
3.97230000004356E-08 |
| Normal-vs-Grade 4 |
2.786400E-02 |
| Grade 1-vs-Grade 2 |
1.514030E-01 |
| Grade 1-vs-Grade 3 |
1.725800E-02 |
| Grade 1-vs-Grade 4 |
3.657100E-03 |
| Grade 2-vs-Grade 3 |
7.893900E-02 |
| Grade 2-vs-Grade 4 |
1.714000E-02 |
| Grade 3-vs-Grade 4 |
2.266800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62581059726108E-12 |
| Normal-vs-ccB subtype |
2.11359999502392E-08 |
| ccA subtype-vs-ccB subtype |
9.375200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37383462781327E-12 |
| Normal-vs-N1 |
2.732200E-01 |
| N0-vs-N1 |
2.465200E-01 |
|
|
